140 related articles for article (PubMed ID: 29070065)
1. Salmonella Typhimurium, the major causative agent of foodborne illness inactivated by a phage lysis system provides effective protection against lethal challenge by induction of robust cell-mediated immune responses and activation of dendritic cells.
Won G; Lee JH
Vet Res; 2017 Oct; 48(1):66. PubMed ID: 29070065
[TBL] [Abstract][Full Text] [Related]
2. A novel Salmonella strain inactivated by a regulated autolysis system and expressing the B subunit of Shiga toxin 2e efficiently elicits immune responses and confers protection against virulent Stx2e-producing Escherichia coli.
Won G; Kim TH; Lee JH
BMC Vet Res; 2017 Feb; 13(1):40. PubMed ID: 28143511
[TBL] [Abstract][Full Text] [Related]
3. A novel adjuvant, a mixture of alum and the general opioid antagonist naloxone, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.
Jazani NH; Sohrabpour M; Mazloomi E; Shahabi S
FEMS Immunol Med Microbiol; 2011 Feb; 61(1):54-62. PubMed ID: 21054579
[TBL] [Abstract][Full Text] [Related]
4. A novel approach for construction of an inactivated typhoid vaccine candidate that effectively augments both humoral and cellular immune responses.
Won G; Kim B; Lee JH
Vaccine; 2017 Jun; 35(25):3333-3341. PubMed ID: 28495314
[TBL] [Abstract][Full Text] [Related]
5. A novel adjuvant, mixture of alum and the beta-adrenergic receptor antagonist propranolol, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.
Mazloomi E; Jazani NH; Shahabi S
Vaccine; 2012 Mar; 30(16):2640-6. PubMed ID: 22342704
[TBL] [Abstract][Full Text] [Related]
6. Assessment of microbiological correlates and immunostimulatory potential of electron beam inactivated metabolically active yet non culturable (MAyNC) Salmonella Typhimurium.
Praveen C; Bhatia SS; Alaniz RC; Droleskey RE; Cohen ND; Jesudhasan PR; Pillai SD
PLoS One; 2021; 16(4):e0243417. PubMed ID: 33861743
[TBL] [Abstract][Full Text] [Related]
7. Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Salmonella typhimurium infection.
Jazani NH; Parsania S; Sohrabpour M; Mazloomi E; Karimzad M; Shahabi S
Immunobiology; 2011 Jun; 216(6):744-51. PubMed ID: 21093956
[TBL] [Abstract][Full Text] [Related]
8. Cinobufagin enhances the protective efficacy of formalin-inactivated Salmonella typhimurium vaccine through Th1 immune response.
Wu SC; Yi PF; Guo X; Zhang LY; Xu DX; Fu YX; Cui ZQ; Shen HQ; Wei XB; Fu BD
Microb Pathog; 2016 Oct; 99():264-270. PubMed ID: 27574776
[TBL] [Abstract][Full Text] [Related]
9. Multifaceted immune responses and protective efficacy elicited by a recombinant autolyzed Salmonella expressing FliC flagellar antigen of F18
Won G; Lee JH
Vaccine; 2016 Dec; 34(50):6335-6342. PubMed ID: 27817960
[TBL] [Abstract][Full Text] [Related]
10. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
[TBL] [Abstract][Full Text] [Related]
11. Improved lysis efficiency and immunogenicity of Salmonella ghosts mediated by co-expression of λ phage holin-endolysin and ɸX174 gene E.
Won G; Hajam IA; Lee JH
Sci Rep; 2017 Mar; 7():45139. PubMed ID: 28332591
[TBL] [Abstract][Full Text] [Related]
12.
Park S; Jung B; Kim E; Hong ST; Yoon H; Hahn TW
Front Immunol; 2020; 11():1277. PubMed ID: 32655567
[TBL] [Abstract][Full Text] [Related]
13. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium.
Jiang H; Hu Y; Yang M; Liu H; Jiang G
Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901
[TBL] [Abstract][Full Text] [Related]
14. A novel method to generate Salmonella Typhi Ty21a ghosts exploiting the λ phage holin-endolysin system.
Won G; Kim B; Lee JH
Oncotarget; 2017 Jul; 8(29):48186-48195. PubMed ID: 28637001
[TBL] [Abstract][Full Text] [Related]
15. Candidate live, attenuated Salmonella enterica serotype Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines.
Abd El Ghany M; Jansen A; Clare S; Hall L; Pickard D; Kingsley RA; Dougan G
Infect Immun; 2007 Apr; 75(4):1835-42. PubMed ID: 17296764
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of efficacy of a new live Salmonella Typhimurium vaccine candidate in a murine model.
Hur J; Kim MY; Lee JH
Comp Immunol Microbiol Infect Dis; 2011 Mar; 34(2):171-7. PubMed ID: 21111480
[TBL] [Abstract][Full Text] [Related]
17. Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers.
Capozzo AV; Cuberos L; Levine MM; Pasetti MF
Infect Immun; 2004 Aug; 72(8):4637-46. PubMed ID: 15271924
[TBL] [Abstract][Full Text] [Related]
18. Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens.
Laughlin RC; Mickum M; Rowin K; Adams LG; Alaniz RC
Vaccine; 2015 Sep; 33(38):5012-9. PubMed ID: 26001432
[TBL] [Abstract][Full Text] [Related]
19. Live and inactivated vaccine regimens against caecal Salmonella Typhimurium colonisation in laying hens.
Groves PJ; Sharpe SM; Muir WI; Pavic A; Cox JM
Aust Vet J; 2016 Oct; 94(10):387-93. PubMed ID: 27671084
[TBL] [Abstract][Full Text] [Related]
20. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
